BR112014019486A8 - Uso de um oligossacarídeo não digerível como um suplemento materno - Google Patents

Uso de um oligossacarídeo não digerível como um suplemento materno

Info

Publication number
BR112014019486A8
BR112014019486A8 BR112014019486A BR112014019486A BR112014019486A8 BR 112014019486 A8 BR112014019486 A8 BR 112014019486A8 BR 112014019486 A BR112014019486 A BR 112014019486A BR 112014019486 A BR112014019486 A BR 112014019486A BR 112014019486 A8 BR112014019486 A8 BR 112014019486A8
Authority
BR
Brazil
Prior art keywords
oligosaccharide
digerable
maternal supplement
immune system
maternal
Prior art date
Application number
BR112014019486A
Other languages
English (en)
Other versions
BR112014019486B1 (pt
BR112014019486A2 (pt
Inventor
Garssen Johan
Hogenkamp Astrid
Catharina Adriana Maria Van Esch Elisabeth
Matthieu Johannes Knippels Leon
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45581889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014019486(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BR112014019486A2 publication Critical patent/BR112014019486A2/pt
Publication of BR112014019486A8 publication Critical patent/BR112014019486A8/pt
Publication of BR112014019486B1 publication Critical patent/BR112014019486B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206Colostrum; Human milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

SUPLEMENTO MATERNO PARA MELHORAR O SISTEMA IMUNOLÓGICO DE UM LACTENTE. São fornecidos composições e métodos para melhorar um sistema imunológico e/ou prevenir um distúrbio relacionado com o sistema imunológico em um indivíduo mamífero, a composição compreendendo um oligossacarídeo não digerível que é para ser administrado a uma fêmea que está amamentando o indivíduo mamífero.
BR112014019486-6A 2012-02-10 2012-02-10 uso de um oligossacarídeo não digerível como um suplemento materno BR112014019486B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/052299 WO2013117235A1 (en) 2012-02-10 2012-02-10 Maternal supplement to enhance immune system of an infant

Publications (3)

Publication Number Publication Date
BR112014019486A2 BR112014019486A2 (pt) 2017-06-20
BR112014019486A8 true BR112014019486A8 (pt) 2017-07-11
BR112014019486B1 BR112014019486B1 (pt) 2020-11-17

Family

ID=45581889

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014019486-6A BR112014019486B1 (pt) 2012-02-10 2012-02-10 uso de um oligossacarídeo não digerível como um suplemento materno

Country Status (12)

Country Link
US (1) US20150080334A1 (pt)
EP (2) EP3075383A1 (pt)
CN (1) CN104168778B (pt)
AU (2) AU2012369298B2 (pt)
BR (1) BR112014019486B1 (pt)
DK (1) DK2811845T3 (pt)
ES (1) ES2564507T3 (pt)
HU (1) HUE027910T2 (pt)
PH (1) PH12014501782A1 (pt)
PL (1) PL2811845T3 (pt)
RU (1) RU2586150C2 (pt)
WO (1) WO2013117235A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055784A (zh) * 2014-06-24 2014-09-24 刘斌 一种婴幼儿用预防过敏的组合物
CN107106582A (zh) * 2014-09-15 2017-08-29 N·V·努特里奇亚 降低后代焦虑

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
CN1871015B (zh) * 2003-10-24 2010-06-16 努特里奇亚有限公司 免疫调节性寡糖
PT1721612E (pt) * 2003-10-24 2009-09-02 Nutricia Nv Oligossacarídeos imunomoduladores
EP1803358A1 (en) * 2005-12-28 2007-07-04 Laboratorios Ordesa, S.L Infant immunological formula
CA2645472C (en) * 2006-03-10 2015-09-15 N.V. Nutricia Use of non-digestable saccharides for giving an infant the best start after birth
JP2008115169A (ja) 2006-10-11 2008-05-22 Meiji Milk Prod Co Ltd 母乳中の総IgA濃度および/または抗原特異的IgA抗体価を増加させる医薬および栄養組成物
EP2117355B1 (en) * 2007-03-13 2017-04-26 N.V. Nutricia Method of improving skills with a composition comprising non-digestible saccharide
PL2589302T3 (pl) * 2007-12-21 2017-05-31 N.V. Nutricia Zastosowanie sfingomieliny i niestrawnych węglowodanów do poprawiania mikroflory jelitowej
CA2719719A1 (en) * 2008-03-28 2009-10-01 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP2662084A1 (en) * 2009-07-15 2013-11-13 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system

Also Published As

Publication number Publication date
CN104168778A (zh) 2014-11-26
CN104168778B (zh) 2017-06-16
BR112014019486B1 (pt) 2020-11-17
EP3075383A1 (en) 2016-10-05
US20150080334A1 (en) 2015-03-19
HUE027910T2 (en) 2016-11-28
ES2564507T3 (es) 2016-03-23
BR112014019486A2 (pt) 2017-06-20
AU2012369298A1 (en) 2014-09-25
RU2014134989A (ru) 2016-04-10
PL2811845T3 (pl) 2016-06-30
EP2811845B1 (en) 2015-12-09
AU2016200609B2 (en) 2018-02-01
DK2811845T3 (en) 2016-03-14
EP2811845A1 (en) 2014-12-17
WO2013117235A1 (en) 2013-08-15
AU2012369298B2 (en) 2016-02-25
PH12014501782B1 (en) 2014-11-17
PH12014501782A1 (en) 2014-11-17
AU2016200609A1 (en) 2016-02-18
RU2586150C2 (ru) 2016-06-10
NZ630141A (en) 2016-08-26

Similar Documents

Publication Publication Date Title
BR112015027281A8 (pt) usos de uma população de nanocarreadores sintéticos que são fixados a imunossupressores e composição compreendendo a referida população de nanocarreadores
TN2014000476A1 (en) D-amino acid compounds for liver disease
SV2015004969A (es) Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
BR112013016929A2 (pt) oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas
DOP2013000239A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso.
BR112014026703A2 (pt) inibidores de dna-pk
BR112015008447A2 (pt) métodos para tratar câncer
BR112015002372A2 (pt) composições e métodos para a redução do teor de álcool no sangue
BR112014031394A8 (pt) Composições compreendendo ciclobenzaprina ou amitriptilina e seus usos via absorção transmucosa oral
BR112013026661A2 (pt) método de entrega de vacina
BR112015008417A8 (pt) composição imunogênica, vacina, e, uso de uma composição imunogênica
BR112014003640A8 (pt) métodos para perda de peso e composições cetogênicas
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
BR112014001472A2 (pt) galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
BR112015027631A2 (pt) Métodos para melhorar perfis de lipídeo usando atrasentana
BR112015030431A2 (pt) formulação de liberação modificada
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
BR112016007390A8 (pt) Vacina de haemophilus parasuis sorotipo tipo quatro
BR112013001462B8 (pt) Composições
BR112016023450A2 (pt) uso de compostos ctla4 para alcançar remissão livre de fármacos em indivíduos com artrite reumatoide precoce
MX2013005820A (es) Peptido derivado de lactoferrina humana para usarse como agente de enmascaramiento de antigenos.
SG194753A1 (en) Induction of il-12 using immunotherapy
NZ626540A (en) Glutamine enriched nutritional composition for preterm infants
BR112014019486A8 (pt) Uso de um oligossacarídeo não digerível como um suplemento materno

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A23L 1/29 , A23L 1/308 , A61K 31/702 , A61K 35/20

Ipc: A23C 9/20 (1980.01), A23L 33/21 (2016.01), A23L 33

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/02/2012, OBSERVADAS AS CONDICOES LEGAIS.